- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05223192
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
April 4, 2025 updated by: Joanne Loewy, Icahn School of Medicine at Mount Sinai
Infants born prematurely at will be asked to participate in this randomized controlled trial at a corrected gestational age of 24-37 weeks.
Infants will be randomly selected to each of the two groups: intervention and control.
Infants in the treatment group will receive six intervention days over a two-week period, 3 sessions per week.
Each intervention day consists of each of the two interventions in a random sequence: no intervention/silence and live ocean disc instrument intervention.
The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation.
Each infant will thus receive control and ocean disc intervention on the same day in the NICU.
Interventions will be given in a randomized order (i.e., first ocean disc or first silence, randomized to AM or PM), with observation occurring for 10 minutes before each intervention, 15 minutes during each intervention, and 10 minutes after each per session.
There will be 3 sessions per week for a two-week randomized treatment schedule.
For each infant, data on total apnea time, mean respiratory rate, heart rate, O2 levels and behavior rating during will be collected.
The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation and hearing damage.
Near-infrared light spectroscopy (NIRS) data on cerebral oxygenation will also be collected.
Observations will be recorded on the infant's activity or when change occurs, such as a pacifier falling out.
Parents and nurses will be asked to behave as they normally would during routine care.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elizabeth Barone
- Phone Number: 212 420-2704
- Email: Elizabeth.Barone@mountsinai.org
Study Contact Backup
- Name: Joanne V Loewy, DA, MT-BC, LCAT
- Phone Number: (212) 420-3484
- Email: joanne.loewy@mountsinai.org
Study Locations
-
-
New York
-
New York, New York, United States, 10003
- Recruiting
- Mount Sinai Hospitals
-
Contact:
- Joanne V Loewy, DA, LCAT, MT-BC
- Phone Number: (212) 420-3484
- Email: joanne.loewy@mountsinai.org
-
Principal Investigator:
- Joanne V Loewy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 8 months (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Newborns born at 24-37 weeks' gestation at Mount Sinai hospital
- Newborn is considered appropriate for clinically indicated music therapy
Exclusion Criteria:
- Infant not expected to survive 24 hours from the time of study entry (To be assessed by a member of the NICU Faculty other than the PI)
- Infant of uncertain viability (gestation <23 weeks, birth weight <500 grams)
- Known or suspected genetic disorder (e.g., Trisomy 21)
- Identified hearing disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Participants in this group will receive the ocean disc music therapy entrainment intervention
|
The studied intervention regards live entrainment with the ocean disc.
Entrainment involves the use of an external stimulus, in the case of this study, an ocean disc instrument.
Motion of the disc creates sounds in synchrony with the breathing of the infant and then in turn can control and influence the infant's regulation of the breath.
|
|
No Intervention: Control group
Participants in this group will not receive any intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: 14 days
|
14 days
|
|
|
Respiratory Rate
Time Frame: 14 days
|
14 days
|
|
|
Oxygen-Saturation Level
Time Frame: 14 days
|
14 days
|
|
|
Weight
Time Frame: 14 days
|
14 days
|
|
|
Cerebral oxygen saturation
Time Frame: 14 days
|
Cerebral oxygen saturation measured using NIRS
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joanne V Loewy, DA, MT-BC, LCAT, Icahn School of Medicine at Mount Sinai
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2022
Primary Completion (Estimated)
March 31, 2026
Study Completion (Estimated)
March 31, 2026
Study Registration Dates
First Submitted
January 24, 2022
First Submitted That Met QC Criteria
January 24, 2022
First Posted (Actual)
February 3, 2022
Study Record Updates
Last Update Posted (Actual)
April 8, 2025
Last Update Submitted That Met QC Criteria
April 4, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY-21-01783
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will be made available upon reasonable request to corresponding author
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity
-
Assiut UniversityNot yet recruitingIntraventricular Hemorrhage of Prematurity
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruitingIntraventricular Hemorrhage of Prematurity
-
Stanford UniversityMedtronic - MITGCompletedIntraventricular Hemorrhage of Prematurity | Complications of PrematurityUnited States
-
Universidade Federal do MaranhãoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
Guilherme Sant'Anna, MDCompleted
-
University of Kansas Medical CenterCompletedComplication of PrematurityUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownPrematurity of FetusTurkey
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPrematurity | Neurodevelopment Outcome | Prematurity ComplicationsFrance
-
Hospital de Clinicas de Porto AlegreBill and Melinda Gates Foundation; Ministry of Health, Brazil; Conselho Nacional...CompletedComplication of PrematurityBrazil
Clinical Trials on Music Therapy Entrainment with Ocean Disc Intervention
-
Icahn School of Medicine at Mount SinaiRecruiting
-
Beth Israel Medical CenterCompletedSepsis | Prematurity | RDS | SGA
-
University of San FranciscoFulbrightCompletedAnxiety | Acute Pain | Self EfficacyIceland
-
Universidad Miguel Hernandez de ElcheCompletedCardiovascular Diseases | Emergencies | Critical Care | Music Therapy
-
Icahn School of Medicine at Mount SinaiCompleted
-
University Diego PortalesRecruiting
-
Wu JiarunCompletedUnrecognized ConditionMalaysia
-
Geisinger ClinicCompletedAlzheimer Disease | Lewy Body Disease | Frontotemporal Dementia | Behavioral and Psychiatric Symptoms of DementiaUnited States
-
Basque Health ServiceAGRUPARTE S.L.RecruitingRespiration, Artificial | Weaning | Music TherapySpain
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedKidney Diseases | Kidney Disease, Chronic | Kidney DysfunctionItaly